Petros Pharmaceuticals Inc PTPI is soaring on abnormally high volume Monday despite no apparent news catalyst.
Petros Pharmaceuticals' average session volume is about 6.4 million over a 100-day period. Monday's trading volume had already exceeded 210 million at publication time.
The stock is trending across social media platforms as traders discuss the stock's short-squeeze potential. 8.91% of the float is sold short, according to data from Benzinga Pro.
The stock surged last week after the company announced that its annual meeting of stockholders would take place on Dec. 22.
See Also: 20 Stocks Moving in Monday's Pre-Market Session
Petros Pharmaceuticals is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring and commercializing innovative therapeutics for men's health issues.
PTPI Price Action: Petros Pharmaceuticals has traded as high as $5.95 and as low as $1.19 over a 52-week period.
The stock was up 111.70% at $4.42 at time of publication.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
